These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36945751)

  • 1. Regulation of beta-amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds.
    Qiu W; Liu H; Liu Y; Lu X; Wang L; Hu Y; Feng F; Li Q; Sun H
    Med Res Rev; 2023 Jul; 43(4):1091-1140. PubMed ID: 36945751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer's Disease: A Review.
    Ahmad SS; Khan S; Kamal MA; Wasi U
    CNS Neurol Disord Drug Targets; 2019; 18(9):657-667. PubMed ID: 31608840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of membrane trafficking in the processing of amyloid precursor protein and production of amyloid peptides in Alzheimer's disease.
    Tan JZA; Gleeson PA
    Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):697-712. PubMed ID: 30639513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of ADAM10 modulation in Alzheimer's disease: a review of the current evidence.
    Khezri MR; Mohebalizadeh M; Ghasemnejad-Berenji M
    Cell Commun Signal; 2023 Mar; 21(1):60. PubMed ID: 36918870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-modifying therapies in Alzheimer's disease: how far have we come?
    Hüll M; Berger M; Heneka M
    Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease.
    Agostinho P; Pliássova A; Oliveira CR; Cunha RA
    J Alzheimers Dis; 2015; 45(2):329-47. PubMed ID: 25589722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment.
    Portelius E; Mattsson N; Andreasson U; Blennow K; Zetterberg H
    Curr Pharm Des; 2011; 17(25):2594-602. PubMed ID: 21728980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APP processing in Alzheimer's disease.
    Zhang YW; Thompson R; Zhang H; Xu H
    Mol Brain; 2011 Jan; 4():3. PubMed ID: 21214928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein.
    Wang YQ; Qu DH; Wang K
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2389-403. PubMed ID: 27338066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin B Deficiency Improves Memory Deficits and Reduces Amyloid-β in hAβPP Mouse Models Representing the Major Sporadic Alzheimer's Disease Condition.
    Hook G; Kindy M; Hook V
    J Alzheimers Dis; 2023; 93(1):33-46. PubMed ID: 36970896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of the alpha-secretase pathway to treat Alzheimer's disease.
    Zhang C; Saunders AJ
    Discov Med; 2007 Aug; 7(39):113-7. PubMed ID: 18093473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging and potential therapies for Alzheimer's disease.
    Griffiths HH; Morten IJ; Hooper NM
    Expert Opin Ther Targets; 2008 Jun; 12(6):693-704. PubMed ID: 18479216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's Disease.
    Shah H; Patel A; Parikh V; Nagani A; Bhimani B; Shah U; Bambharoliya T
    CNS Neurol Disord Drug Targets; 2020; 19(3):184-194. PubMed ID: 32452328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation and Glycosylation of Amyloid-β Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer's Disease.
    Song XJ; Zhou HY; Sun YY; Huang HC
    J Alzheimers Dis; 2021; 84(3):937-957. PubMed ID: 34602469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In search of pathogenic amyloid β-peptide in familial Alzheimer's disease.
    Wolfe MS
    Prog Mol Biol Transl Sci; 2019; 168():71-78. PubMed ID: 31699328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.
    Gerber H; Wu F; Dimitrov M; Garcia Osuna GM; Fraering PC
    J Biol Chem; 2017 Mar; 292(9):3751-3767. PubMed ID: 28096459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The past, present, and future of disease-modifying therapies for Alzheimer's disease.
    Suzuki K; Iwata A; Iwatsubo T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):757-771. PubMed ID: 29225305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.